Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Construction at Qwaqwa Campus creates jobs for local community
2010-05-28

At the construction site hand-over ceremony are, from the left: Dr
Elias Malete, Dr Dipane Hlalele, Prof. WF van Zyl and Mr Derek Canavan
(Freelance Construction)
Photo: Thabo Kessah


Local labour is set to benefit from at least 20 job opportunities that will be created during the building of new facilities valued at R13,5 million for the Faculty of Education on the Qwaqwa Campus of the University of the Free State (UFS).

This was announced by Mr Derek Canavan, an architect from Freelance Construction, during the sod-turning ceremony held on the construction site recently.

The soon to be built facilities will include a 100-seater lecture hall, two 50-seater classrooms, an office block, ablution facilities, two separate laboratories for biology and science, as well as an IT laboratory with 70 work stations. All these facilities will be user-friendly to the disabled students.

Addressing a contingent of brains behind the project that included Mr Nico Janse van Rensburg, Manager of Physical Planning at the UFS, Dr Elias Malete, the Qwaqwa Campus Principal, said that this addition to the existing infrastructure would enable the campus to meet its enrolment and output challenges.

“These new facilities will no doubt increase the university’s academic and research capacity and will certainly help us respond positively to Minister Blade Nzimande’s call to institutions of higher learning to improve on scientific research. We are therefore pleased with this multi-million rand investment from the National Department of Education and the UFS,” he concluded.

Also attending was Dr Dipane Hlalele, Programme Head in the faculty, who was also pleased with the new facilities. “These facilities will help us to answer to our community’s needs of pre-school and foundation-phase teacher training which will be added to our study programme in January 2011. We will be introducing a new B.Ed. degree in Pre-school and Foundation phases and these facilities will help in the production of quality teachers for the benefit of our community,” he said.

The new building is expected to be ready for usage in June 2011.

Media Release
Issued by: Lacea Loader
Director: Strategic Communication (acting)
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl@ufs.ac.za  
27 May 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept